recently, salubris received the notice of approval of clinical trials approved and issued by national medical products administration, which means that salubris was approved to carry out clinical trials of allisartan isoproxil indapamide sustained-re
recently, salubris received the notice of approval of clinical trials approved and issued by national medical products administration, which means that salubris was approved to carry out clinical trials of "allisartan isoproxil amlodipine besylate t
sal007 is expected to provide a new choice for the treatment of chronic heart failure, and bring new hope to the extensive patients with chronic heart failure.